DE69432470T2 - Dna kodierend für prostaglandin rezeptor ip - Google Patents

Dna kodierend für prostaglandin rezeptor ip Download PDF

Info

Publication number
DE69432470T2
DE69432470T2 DE69432470T DE69432470T DE69432470T2 DE 69432470 T2 DE69432470 T2 DE 69432470T2 DE 69432470 T DE69432470 T DE 69432470T DE 69432470 T DE69432470 T DE 69432470T DE 69432470 T2 DE69432470 T2 DE 69432470T2
Authority
DE
Germany
Prior art keywords
prostaglandin receptor
receptor
dna coding
host cells
dna encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69432470T
Other languages
English (en)
Other versions
DE69432470D1 (de
Inventor
Mark Abramovitz
Yves Boie
Richard Grygorczyk
Kathleen Metters
Thomas H Rushmore
Deborah M Slipetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Canada Inc
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22461361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69432470(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of DE69432470D1 publication Critical patent/DE69432470D1/de
Publication of DE69432470T2 publication Critical patent/DE69432470T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69432470T 1993-10-06 1994-10-03 Dna kodierend für prostaglandin rezeptor ip Expired - Lifetime DE69432470T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/134,012 US5516652A (en) 1993-10-06 1993-10-06 DNA encoding prostaglandin receptor IP
PCT/CA1994/000548 WO1995009872A1 (en) 1993-10-06 1994-10-03 Dna encoding prostaglandin receptor ip

Publications (2)

Publication Number Publication Date
DE69432470D1 DE69432470D1 (de) 2003-05-15
DE69432470T2 true DE69432470T2 (de) 2004-01-29

Family

ID=22461361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69432470T Expired - Lifetime DE69432470T2 (de) 1993-10-06 1994-10-03 Dna kodierend für prostaglandin rezeptor ip

Country Status (8)

Country Link
US (3) US5516652A (de)
EP (1) EP0722462B1 (de)
JP (1) JP3029125B2 (de)
AT (1) ATE236932T1 (de)
CA (1) CA2173595C (de)
DE (1) DE69432470T2 (de)
ES (1) ES2192561T3 (de)
WO (1) WO1995009872A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3692536B2 (ja) * 1994-02-10 2005-09-07 小野薬品工業株式会社 プロスタグランジンｉ２受容体
US6395878B1 (en) * 1994-05-05 2002-05-28 Allergan Sales, Inc. Nucleic acid encoding a human EP prostaglandin receptor
WO1996023066A2 (en) 1995-01-26 1996-08-01 Merck Frosst Canada Inc. Prostaglandin receptor, dp
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US6673760B1 (en) * 2000-06-29 2004-01-06 Ecolab Inc. Rinse agent composition and method for rinsing a substrate surface
US20040253668A1 (en) * 2002-01-22 2004-12-16 Ramanathan Chandra S. Novel G-protein coupled receptor (GPCR) variants and methods of use thereof
DE10229872A1 (de) * 2002-07-03 2004-01-29 Curevac Gmbh Immunstimulation durch chemisch modifizierte RNA
JP2006517576A (ja) * 2003-02-14 2006-07-27 メディカル リサーチ カウンシル 病理的子宮症状の治療のためのｉｐレセプターアンタゴニスト
DE102006035618A1 (de) * 2006-07-31 2008-02-07 Curevac Gmbh Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
AU2007280690C1 (en) 2006-07-31 2012-08-23 Curevac Gmbh Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
EP2548960B1 (de) 2008-01-31 2018-01-31 CureVac AG Nukleinsäure der Formel (NuGIXmGnNv)a und Derivate davon als immunstimulierendes Mittel/Adjuvans
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
WO2011159904A1 (en) * 2010-06-17 2011-12-22 The Trustees Of The University Of Pennsylvania Methods for predicting cellular signaling responses to combinatorial stimuli
ES2622519T3 (es) 2010-07-14 2017-07-06 Novartis Ag Componentes heterocíclicos agonistas del receptor IP
SG186706A1 (en) 2010-07-30 2013-02-28 Curevac Gmbh Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
ES2565826T3 (es) 2012-01-13 2016-04-07 Novartis Ag Pirroles fusionados como agonistas del receptor IP para el tratamiento de hipertensión arterial pulmonar (PAH) y trastornos relacionados
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
US9604981B2 (en) 2013-02-13 2017-03-28 Novartis Ag IP receptor agonist heterocyclic compounds
AU2014310934B2 (en) 2013-08-21 2019-09-12 CureVac SE Respiratory syncytial virus (RSV) vaccine
WO2015149944A2 (en) 2014-04-01 2015-10-08 Curevac Gmbh Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant

Also Published As

Publication number Publication date
US5728808A (en) 1998-03-17
ES2192561T3 (es) 2003-10-16
ATE236932T1 (de) 2003-04-15
US5516652A (en) 1996-05-14
EP0722462B1 (de) 2003-04-09
WO1995009872A1 (en) 1995-04-13
CA2173595A1 (en) 1995-04-13
JP3029125B2 (ja) 2000-04-04
DE69432470D1 (de) 2003-05-15
JPH09503213A (ja) 1997-03-31
CA2173595C (en) 2001-06-12
EP0722462A1 (de) 1996-07-24
US6365360B1 (en) 2002-04-02

Similar Documents

Publication Publication Date Title
DE69432470T2 (de) Dna kodierend für prostaglandin rezeptor ip
ATE170532T1 (de) Prostaglandin rezeptor fp und kodierende dns
CA2170509A1 (en) Dna encoding prostaglandin receptor ep2
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
ATE157398T1 (de) Prostaglandinrezeptor ep1 kodierende dna
WO1996023066A3 (en) Prostaglandin receptor, dp
PT765394E (pt) Lacases myceliophthora purificadas e acidos nucleicos que as codificam
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
DE3789273D1 (de) Kodierungssystem zur Reduktion der Redundanz.
ATE196651T1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
ATE415480T1 (de) B7l-1 moleküle
ATE172471T1 (de) Prostaglandin rezeptor ep3 und kodierende dns
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
AR001014A1 (es) Una molecula de dna aislada que codifica daunorubicina 14-hidroxilasa, dicha daunorubicina 14-hidroxilasa, procedimiento para producir dicho dna,vector que comprende dicho dna, celula huesped que contiene dicho vector, procedimiento para producir doxorubicina mediante dicha celula
NO905545D0 (no) Renset ubiquitinhydrolase, dna-sekvenser som koder for samme, samt anvendelse for isolering av polypeptider.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK FROSST CANADA LTD., KIRKLAND, QUEBEC, CA